1. Home
  2. DPG vs NPCE Comparison

DPG vs NPCE Comparison

Compare DPG & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duff & Phelps Utility and Infrastructure Fund Inc.

DPG

Duff & Phelps Utility and Infrastructure Fund Inc.

HOLD

Current Price

$14.42

Market Cap

535.3M

Sector

Finance

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$14.17

Market Cap

485.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DPG
NPCE
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
535.3M
485.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
DPG
NPCE
Price
$14.42
$14.17
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
108.1K
171.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
N/A
$25.95
Revenue Next Year
N/A
$0.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$10.45
$7.56
52 Week High
$14.96
$18.97

Technical Indicators

Market Signals
Indicator
DPG
NPCE
Relative Strength Index (RSI) 55.66 42.40
Support Level $12.37 $9.52
Resistance Level $14.68 $16.96
Average True Range (ATR) 0.22 0.83
MACD -0.06 -0.05
Stochastic Oscillator 24.68 50.16

Price Performance

Historical Comparison
DPG
NPCE

About DPG Duff & Phelps Utility and Infrastructure Fund Inc.

Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund, and its objective is to seek total return, derived mainly from a high level of current income, with an emphasis on providing tax-advantaged dividend income and growth in current income, and secondarily from capital appreciation.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: